University of Campania Luigi Vanvitell, Naples (Italy)
Follow
Contributor content
Presentation
Combination of an oral H2S donor to dapagliflozin provides additional therapeutic benefit in a cardiorenal model of heart failure with preserved ejection fraction (HFpEF)
